Neoplasm Proteins

All categories
DBCAT000212Pharmacologic class

Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. A DrugBank category of 10 drugs. 3 of them are approved.

Also known as
Proteins, Neoplasm
Drugs

What you can answer from here — as of August 24, 2016

10DrugsEach linked to its full drug card
Listed above
11Drug targetsEvery drug–target pair in the class, with bond type
Sign in
88Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
3Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Neoplasm Proteins share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In